Vera Therapeutics (VERA)
(Delayed Data from NSDQ)
$19.79 USD
+0.07 (0.35%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $19.78 -0.01 (-0.05%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth D Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Vera Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
VERA 19.79 +0.07(0.35%)
Will VERA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for VERA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for VERA
Wall Street Analysts Think Vera Therapeutics (VERA) Could Surge 27.26%: Read This Before Placing a Bet
VERA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for VERA
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | VERA Stock News
JP Morgan Adjusts Price Target for Vera Therapeutics (VERA), Maintains Rating | VERA Stock News
Vera Therapeutics GAAP EPS of -$1.20 misses by $0.50
Vera (VERA) Reports Strong Financial Position to Support Future Initiatives
Vera Therapeutics (VERA) Prepares for FDA Approval Following Promising Trial Results